Consider Endari for Patients on Hydroxyurea Who Still Have Sickle Cell Crises
December 2017
L-glutamine (Endari, en-DAH-ree) is the first sickle cell treatment to be approved in almost 20 years.
L-glutamine is for patients 5 years and older to reduce acute sickle cell complications...such as pain crises, acute chest syndrome, etc.
It's thought to work by reducing oxidative damage to "sickled" red blood cells. This may prevent the cells from adhering to blood vessels, causing thrombosis and reducing blood flow.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote